# Phase 5.3.2 — Final Scientific Wording Correction and Comprehensive Manuscript Audit Report

> **Document Type:** COMPREHENSIVE READ-ONLY SCIENTIFIC CONSISTENCY AUDIT REPORT  
> **Evaluation Subject:** Complete Manuscript Draft and Research Artifacts for the HBB Gene Mutation Analyzer Study  
> **Audited Manuscript Sections:**  
> 1. `research/manuscript/PHASE5_2A_TITLE_ABSTRACT.md` (Title & Structured Abstract)  
> 2. `research/manuscript/PHASE5_2B_INTRODUCTION.md` (Introduction)  
> 3. `research/manuscript/PHASE5_2C_METHODS.md` (Methods)  
> 4. `research/manuscript/PHASE5_2D_RESULTS.md` (Results)  
> 5. `research/manuscript/PHASE5_3_DISCUSSION_LIMITATIONS_CONCLUSION.md` (Discussion, Limitations, Conclusion)  
> **Audited Supporting & Governance Artifacts:**  
> 6. `research/manuscript/PHASE5_3_1_SCIENTIFIC_CORRECTION_REPORT.md`  
> 7. `research/manuscript/MANUSCRIPT_EVIDENCE_MATRIX.md`  
> 8. `research/manuscript/PHASE5_2E_CROSS_SECTION_AUDIT.md`  
> 9. `research/protocol/PHASE2C_BENCHMARK_PROTOCOL.md` (Locked Protocol)  
> 10. `research/results/phase2c_benchmark_summary.json` (Benchmark Outputs)  
> 11. `research/results/PHASE2C_CLASS_RESULTS.md` (Stratified Results)  
> 12. `research/results/CP4_4_SCIENTIFIC_INTERPRETATION_BIAS_AUDIT.md` (Bias & Provenance Audit)  
> 13. `research/manifest/phase2c_primary.json` (Frozen Primary Evaluation Cohort)  
> **Evaluation Date:** 2026-10-10  
> **Auditor Role:** Critical Scientific Reviewer & Reproducibility Auditor  
> **Final Audit Verdict:** **PASS**

---

## 1. Confirmation of Part A Wording Correction

### 1.1 Corrected Location
- **File:** `research/manuscript/PHASE5_3_DISCUSSION_LIMITATIONS_CONCLUSION.md`
- **Section:** Discussion Section 4 (*"Implications for Deterministic and Reference-Aware Computation"*), paragraph 1 (lines 43–45).

### 1.2 Text Replacement Verification
The overbroad claim asserting that deterministic computation avoids hallucinations or non-reproducibility inherent to generative models was removed and replaced with the exact qualified language:

> **Pre-Correction Text (Discussion §4, Para 1):**  
> *"These findings illustrate the scientific utility of pure, deterministic rule-based computation in genomic pipelines. In contemporary bioinformatics, machine-learning architectures and artificial intelligence models are increasingly explored for variant interpretation workflows. However, sequence-to-consequence derivation is fundamentally a deterministic biochemical process governed by known reference coordinates and the universal genetic code. While the present study did not benchmark large language models (LLMs) or stochastic classifiers directly against the deterministic pipeline, relying on generative text prediction for canonical codon translation introduces known risks of non-deterministic outputs, hallucinations, and untraceable syntax errors into clinical pipelines."*

> **Post-Correction Text (Discussion §4, Para 1):**  
> *"These findings illustrate the operational characteristics of deterministic computation in genomic pipelines. The use of deterministic, rule-based computation makes molecular consequence outputs reproducible under a fixed implementation and reference sequence. Although generative AI can support auxiliary evidence retrieval and summarization, this study did not directly compare LLM-based methods with the deterministic engine and therefore draws no conclusions about their relative error rates or reliability. Deterministic execution itself does not imply that software is error-free; a rule-based pipeline can still contain implementation bugs, incorrect biological assumptions, or incomplete rules."*

### 1.3 Architectural and Safety Boundary Preservation
- **Decoupled Architecture Preserved:** The text accurately explains that core consequence derivation is executed in pure Python without statistical heuristics or network calls (`backend/app/core/consequences.py`), while generative AI capabilities are strictly segregated into an auxiliary, non-evaluative literature retrieval module (`backend/app/ai.py`).
- **No Claim of Error-Free Software:** The revised text explicitly disclaims that deterministic software is inherently error-free, noting that rule-based systems can still harbor implementation defects, incorrect biological assumptions, or unhandled edge cases.
- **Zero Inferred Superiority:** The manuscript draws no conclusions regarding the comparative error rates or reliability of LLMs versus deterministic pipelines.

---

## 2. Numerical Traceability Matrix

Every quantitative claim, sample size, confidence interval, and sub-classification across the manuscript sections was traced directly to the stored repository artifacts:

| Numerical Metric | Manuscript Reported Value | Authoritative Repository Artifact | Exact Artifact Location & Value | Cross-Section Consistency |
|---|:---:|---|---|:---:|
| **Primary Cohort Denominator ($N$)** | **55** | `research/manifest/phase2c_primary.json` | `candidate_count: 55`, `len(candidates): 55` | **Consistent** across Abstract, Methods, Results, Discussion, Limitations, Conclusion |
| **Primary Consequence Matches ($k$)** | **55** | `research/results/phase2c_benchmark_summary.json` | `primary_endpoint.k: 55`, `discrepancies: 0` | **Consistent** ($A$ vs $C$, 55/55) across all sections |
| **Primary Concordance Rate (%)** | **100.00%** | `research/results/phase2c_benchmark_summary.json` | `primary_endpoint.percentage: 100.0` | **Consistent** across all sections |
| **Exact 95% Clopper-Pearson CI** | **[93.51%, 100.00%]** | `research/results/phase2c_benchmark_summary.json` | `primary_endpoint.ci_95_clopper_pearson: [93.51, 100.0]` | **Consistent** across Abstract, Methods, Results, Discussion, Conclusion |
| **Secondary Exact Protein Matches ($k$)** | **28** | `research/results/phase2c_benchmark_summary.json` | `secondary_endpoints.protein_consequence_concordance.k: 28` | **Consistent** (28/55) across Abstract, Methods, Results, Discussion |
| **Secondary Protein Concordance (%)** | **50.91%** | `research/results/phase2c_benchmark_summary.json` | `secondary_endpoints.protein_consequence_concordance.percentage: 50.91` | **Consistent** across Abstract, Methods, Results, Discussion |
| **Secondary Exact 95% Clopper-Pearson CI** | **[37.07%, 64.65%]** | `research/results/phase2c_benchmark_summary.json` | `secondary_endpoints.protein_consequence_concordance.ci_95_clopper_pearson: [37.07, 64.65]` | **Consistent** across Methods, Results, Discussion |
| **Protein Format Differences (Frameshifts)** | **20** | `research/results/phase2c_benchmark_summary.json` | `status_breakdown.DISCREPANCY: 20`, `MOLECULAR_AGREEMENT_PROTEIN_DIFFERENCE: 20` | **Consistent** (9 C04 deletions, 11 C06 duplications) across all sections |
| **Incomplete External Protein Annotations** | **5** | `research/results/phase2c_benchmark_summary.json` | `status_breakdown.INCOMPLETE: 5`, `EXTERNAL_ANNOTATION_INCOMPLETE: 5` | **Consistent** (5 C09 splice acceptors) across all sections |
| **Non-Applicable Protein Comparisons** | **2** | `research/results/phase2c_benchmark_summary.json` | `status_breakdown.NOT_APPLICABLE: 2` | **Consistent** (2 C11 3' UTR non-coding) across Methods, Results, Discussion |
| **Ten-Tier Unpopulated Error Categories** | **0** | `research/results/phase2c_benchmark_summary.json` | `ENGINE_ERROR: 0`, `REFERENCE_MISMATCH: 0`, `HGVS_AMBIGUITY: 0`, etc. | **Consistent** across Methods, Results, Discussion |
| **Synthetic Robustness Controls ($N$)** | **18** | `research/results/phase2c_benchmark_summary.json` | `robustness_experiment.n: 18` | **Consistent** (Experiment D, Class C12) across all sections |
| **Robustness Graceful Rejections ($k$)** | **18 (100.0%)** | `research/results/phase2c_benchmark_summary.json` | `robustness_experiment.gracefully_rejected_k: 18`, `rejection_percentage: 100.0` | **Consistent** (18/18, 0 unhandled crashes) across all sections |
| **Robustness Exact 95% Clopper-Pearson CI** | **[81.47%, 100.00%]** | `research/results/phase2c_benchmark_summary.json` | `robustness_experiment.ci_95_clopper_pearson: [81.47, 100.0]` | **Consistent** across Methods, Results, Discussion |
| **Software Regression Invariance ($A$ vs $B$)** | **55/55 (100.0%)** | `research/results/phase2c_benchmark_summary.json` | `software_regression_metadata.k: 55`, `n: 55`, `percentage: 100.0` | **Consistent** (strictly isolated from $A$ vs $C$) across all sections |
| **Represented Biological Classes ($n$)** | **7 classes** | `research/results/PHASE2C_CLASS_RESULTS.md` | C01 ($n=14$), C02 ($n=3$), C03 ($n=10$), C04 ($n=9$), C06 ($n=12$), C09 ($n=5$), C11 ($n=2$) | **Consistent** across Methods, Results, Discussion, Limitations |
| **Unrepresented Biological Classes ($n = 0$)** | **4 classes** | `research/results/PHASE2C_CLASS_RESULTS.md` | C05 ($n=0$), C07 ($n=0$), C08 ($n=0$), C10 ($n=0$) | **Consistent** across Abstract, Intro, Results, Limitations, Conclusion |
| **Historical Legacy Codon Offsets** | **33 (60.00%)** | `research/results/PHASE2C_ERROR_REGISTER.md` | `legacy_alias_count: 33`, `33/55` | **Consistent** across Results, Discussion |

**Numerical Traceability Finding:** 100% of reported figures match stored repository artifacts bit-for-bit. Zero discrepancies, ungrounded estimates, or post-hoc recalculations exist.

---

## 3. Section-by-Section Scientific Consistency Assessment

### 3.1 Title and Abstract (`PHASE5_2A_TITLE_ABSTRACT.md`)
- **Title Alignment:** The selected title (*"Concordance Evaluation of Deterministic HBB Molecular Consequence Prediction Against a Curated ClinVar-Derived External Annotation Reference"*) strictly follows the recommended central claim (**CLM-TIT-05**) authorized in `MANUSCRIPT_EVIDENCE_MATRIX.md`.
- **Abstract Structure:** The structured abstract (Background, Objective, Methods, Results, Limitations, Conclusion) contains exactly 298 words (within 250–300 word requirement).
- **Endpoint Separation:** Strictly defines the primary comparison as runtime deterministic consequence prediction versus curated ClinVar-derived external molecular annotations, isolating internal regression baselines ($B$) and synthetic robustness controls ($N = 18$).
- **Disclosures:** Explicitly discloses CP2.2 incorporation/verification bias, 100% ClinVar origin, zero non-ClinVar corroborations, four unrepresented classes ($n=0$ for C05, C07, C08, C10), and small sample sizes for C02 ($n=3$) and C11 ($n=2$).
- **Prohibited Claims:** Zero instances of clinical validation, diagnostic accuracy, or pathogenicity prediction.

### 3.2 Introduction (`PHASE5_2B_INTRODUCTION.md`)
- **Biological & Nomenclature Context:** Grounded in authoritative *HBB* literature (Thein 2013; Weatherall 2010; Taher et al. 2018; Giardine et al. 2007) and modern HGVS standards (den Dunnen et al. 2016). Accurately explains the historical mature $\beta$-globin -1 codon offset.
- **Reference Transcript Standard:** Accurately cites NCBI RefSeq (O'Leary et al. 2016) and the MANE Select initiative (Morales et al. 2022) establishing `NM_000518.5` as the invariant reference transcript.
- **Conceptual Separation:** Section 4 rigorously articulates the boundary between objective molecular consequence derivation and evaluative clinical pathogenicity scoring in accordance with ACMG/AMP guidelines (Richards et al. 2015; Rehm et al. 2015).
- **Comparator Characterization:** Section 5 defines ClinVar as an aggregated submitter archive representing consensus assertions rather than experimental ground truth (Landrum et al. 2018; Harrison et al. 2017).
- **Explicit Scope Disclosures:** Section 7 explicitly discloses that cohort admission required `comparison_status == "EXACT_AGREEMENT"` during CP2.2, introduces incorporation/verification bias, limits generalization to unseen variants, and enumerates the four zero-count mutation classes.
- **Word Count:** 1,276 words (compliant with the 900–1,300 word target).

### 3.3 Methods (`PHASE5_2C_METHODS.md`)
- **Mathematical Decoupling:** Mathematically defines Entity $A$ (runtime engine output), Entity $B$ (frozen expected output), and Entity $C$ (normalized external annotation), establishing that primary concordance evaluates $A$ vs $C$ with $B$ completely excluded.
- **Reference Geometry:** Details the 626-bp transcribed model of `NM_000518.5` across three exons and two introns, coding sequence ($c.1..c.444$), and the 147-amino-acid pre-protein (`NP_000509.1`).
- **Input Validation Pipeline:** Formally describes the five-stage HGVS parsing and coordinate validation pipeline.
- **Decoupling from AI:** Explicitly documents that generative AI is restricted to an auxiliary literature module (`backend/app/ai.py`) and was completely isolated from consequence derivation.
- **Curation Funnel & Selection Bias:** Graphically reconstructs the candidate qualification funnel from $N = 314$ down to $N = 55$ and provides a dedicated methodological subsection explaining incorporation/verification bias.
- **Statistical Prespecification:** Pre-specifies exact Clopper-Pearson binomial confidence interval formulas and the ten-tier comparison hierarchy.

### 3.4 Results (`PHASE5_2D_RESULTS.md`)
- **Protocol Integrity:** Documents pre-execution verification of dataset hash (`39eb60de...`), protocol hash (`e4bad0a0...`), and engine commit (`845f595c...`), with zero candidate overlap against the historical test manifest (`2f6b8842...`).
- **Primary Endpoint Reporting:** Reports 55/55 concordance (100.00%, exact 95% CI: [93.51%, 100.00%]) with zero runtime exceptions or unhandled crashes across the 10-tier comparison hierarchy.
- **Secondary Protein Breakdown:** Discloses 28 exact matches (50.91%), 20 format discrepancies from ClinVar truncated frameshift representations, 5 incomplete splice acceptor strings, and 2 non-coding UTR variants.
- **Class Stratification:** Table 3 documents all 11 biological classes, explicitly detailing candidate counts, confidence intervals, and the biological/filtering reasons for the four zero-count classes (C05, C07, C08, C10).
- **Separate Experiment Reporting:** Reports synthetic robustness controls ($18/18$ graceful rejections) in Experiment D, software regression invariance ($55/55$ match against Entity $B$), and legacy codon tracking (33/55 aliases resolved).

### 3.5 Discussion, Limitations, and Conclusion (`PHASE5_3_DISCUSSION_LIMITATIONS_CONCLUSION.md`)
- **Principal Findings & Evidentiary Tiers:** Discussion §1 and §2 ground the 55/55 result in computational rule execution fidelity and separate correct comparison execution and cohort concordance from prospective generalization to unseen variants.
- **Protein Syntax Analysis:** Discussion §3 analyzes the divergence between full HGVS protein translation and database shorthand conventions (den Dunnen et al. 2016; Landrum et al. 2018).
- **Deterministic vs. Generative AI:** Discussion §4 incorporates the Part A correction: states that deterministic computation makes outputs reproducible under fixed implementation and reference sequence, notes that LLMs were not directly benchmarked, disclaims comparative error rate conclusions, and clarifies that deterministic software is not inherently error-free.
- **Tool Comparison:** Discussion §5 provides a balanced assessment of VEP and ANNOVAR for high-throughput whole-genome annotation, framing the present tool as a focused, lightweight locus-specific engine for *HBB* without asserting superiority. Cites Richards et al. (2015) for ACMG/AMP guidelines and McLaren et al. (2016) / Wang et al. (2010) for consequence categorization, with zero unsupported predictor citations.
- **Benchmark Reproducibility:** Discussion §6 frames cryptographic digests as confirming artifact identity and execution consistency rather than preventing retrospective selection bias.
- **Limitations:** Systematically details incorporation bias, sole ClinVar provenance without orthogonal secondary corroboration, unrepresented mutation classes, protein annotation incompleteness, and small-subgroup statistical uncertainty.
- **Conclusion:** Reaffirms rule execution fidelity and concordance with curated ClinVar-derived external annotations, strictly disclaiming biological ground truth, clinical validity, or diagnostic accuracy.
- **Word Counts:** Discussion: 1,376 words; Limitations: 695 words; Conclusion: 182 words; References: 378 words; Total prose body: 2,253 words (fully compliant).

---

## 4. Audit of Selection Bias and External Annotation Provenance

### 4.1 Curation Incorporation / Verification Bias
- **Mechanism:** In stage CP2.2 curation (`run_independent_verification.py`, lines 231–246), candidate admission into the `PROPOSED_PRIMARY` qualification pool required that runtime engine output match external annotations (`comparison_status == "EXACT_AGREEMENT"`).
- **Impact:** Variants triggering parser rejections, coordinate mismatches, or divergent consequence predictions were systematically diverted into `REVIEW_REQUIRED`, `CONDITIONAL`, or `DO_NOT_USE`. The subsequent human review workflow (`run_cp2_3_human_review.py`) sampled exclusively from this pre-screened pool.
- **Manuscript Representation:** Every section of the manuscript explicitly documents this mechanism:
  - Abstract Limitations: *"Cohort admission incorporated deterministic engine agreement during curation, introducing incorporation/verification bias."*
  - Introduction §7: *"During CP2.2 curation, admission to the proposed primary cohort required deterministic engine agreement (`comparison_status == "EXACT_AGREEMENT"`)... creating incorporation or verification bias."*
  - Methods §6: Dedicated subsection explaining the curation rule, epidemiological definition of verification bias, and resulting cohort enrichment.
  - Results §1: Discloses that admission required engine concordance, evaluating rule execution fidelity on curated records rather than an unselected clinical sample.
  - Limitations §1: Elaborates on the epidemiological distinction between frozen execution immutability and independent cohort selection.
  - Conclusion: Identifies incorporation bias as a primary boundary on scientific interpretation.

### 4.2 External Reference Annotation Provenance
- **Single Source Dependency:** 100% (55/55) of primary cohort candidates originated from NCBI ClinVar records under RefSeq `NM_000518.5`.
- **Zero Independent Corroboration:** Exactly 0 candidates possessed independent biological corroboration dossiers outside of ClinVar (`independent_non_clinvar_corroboration == "NONE"`).
- **Consensus vs. Biological Truth:** The manuscript repeatedly and explicitly emphasizes that while 54 of 55 variants (98.18%) possessed $\ge 2$-star review status, multiple laboratory submissions to a public archive establish submitter consensus, not independent biological ground truth (Harrison et al. 2017).

---

## 5. Audit of Citations, Comparative Claims, and Terminology

### 5.1 Preregistration Terminology Audit
- **Audit Rule:** No claim of external public preregistration without an official registry accession.
- **Findings:** Zero occurrences of `"pre-registered"` or `"preregistration"`. All protocol locking descriptions use `"predefined, protocol-locked evaluation framework"` or `"predefined protocols locked prior to execution"`, accurately reflecting internal repository milestones.

### 5.2 Cryptographic Integrity Claims Audit
- **Audit Rule:** SHA256 hashes must be described as verifying artifact identity and provenance against pre-recorded values, not as proof that selection bias or selective reporting was impossible.
- **Findings:** In Discussion §6, cryptographic digests are explicitly framed as confirming artifact identity and verifying zero code or manifest drift during benchmark execution; the text explicitly adds that cryptographic hashing does not remove retrospective curation selection bias.

### 5.3 Comparative Claims (AI & Competing Tools) Audit
- **Audit Rule:** No unsupported claims that deterministic software is universally superior to AI or external tools (VEP, ANNOVAR).
- **Findings:**
  - Discussion §4 explicitly states that LLMs were not directly benchmarked against the deterministic engine and draws no conclusions about relative error rates.
  - Discussion §4 disclaims that deterministic software is error-free, noting that rule-based systems can contain bugs, incorrect assumptions, or incomplete rules.
  - Discussion §5 characterizes VEP and ANNOVAR in terms of their intended high-throughput whole-genome design, framing the present tool as an auditable, lightweight locus-specific implementation for *HBB* without asserting superiority.

### 5.4 Literature Citation Accuracy Audit
- **Audit Rule:** Citations must directly support the assertions attributed to them; no tools attributed to authors who did not introduce them.
- **Findings:**
  - Unsupported predictor citations (`PolyPhen-2`, `SIFT`, `CADD`, `AlphaMissense`) are completely absent.
  - Richards et al. (2015) is cited strictly for the ACMG/AMP clinical variant interpretation framework and separating molecular consequence (PVS1) from in silico pathogenicity prediction (PP3).
  - McLaren et al. (2016) and Wang et al. (2010) are cited strictly for deterministic consequence categorization on transcripts.
  - Clopper & Pearson (1934) is cited for exact binomial confidence limits.
  - All 17 bibliographic entries in the Discussion/Limitations/Conclusion reference section are cited in-text and correspond to verified sources in `research/manuscript/PHASE5_2B_LITERATURE_MAP.md`.

### 5.5 Prohibited and Sensitive Terminology Audit
An automated regex scan across all drafted manuscript sections confirms:
- `"100% accuracy"`: 0 occurrences
- `"independently validated"`: 0 occurrences
- `"consensus database alignment"`: 0 occurrences (standardized to `"curated ClinVar-derived external molecular annotations"`)
- `"ground truth"`: 3 occurrences in `PHASE5_3_DISCUSSION_LIMITATIONS_CONCLUSION.md`, all strictly in negative disclaimers (*"strict exclusion of clinical validation and biological ground truth claims"*, *"represent diagnostic laboratory consensus rather than independent biological ground truth"*, *"not independent biological ground truth, clinical validity, or diagnostic accuracy"*).

---

## 6. Cryptographic Hash Verification Results

Pre-execution and post-audit read-only verification of frozen repository baselines:

```
[HASH-VERIFY-1] Primary Manifest
File:     research/manifest/phase2c_primary.json
Expected: 39eb60de0e60dea8a76f2290912905b197fb1a04b738f72b0493bcdab2e0eb96
Observed: 39eb60de0e60dea8a76f2290912905b197fb1a04b738f72b0493bcdab2e0eb96
Size:     59,605 bytes
Status:   PASS (EXACT MATCH)

[HASH-VERIFY-2] Historical Test Manifest
File:     research/manifest/frozen_test.json
Expected: 2f6b88422b82d3f74c20f00985a34ffb5c1c78c311e4d8b584bc732cf5fc5994
Observed: 2f6b88422b82d3f74c20f00985a34ffb5c1c78c311e4d8b584bc732cf5fc5994
Size:     31,093 bytes
Status:   PASS (EXACT MATCH)

[HASH-VERIFY-3] Locked Benchmark Protocol
File:     research/protocol/PHASE2C_BENCHMARK_PROTOCOL.md
Expected: e4bad0a095cdfa8112a649f3d8a0794cf0078d218611bb965020b100ba368969
Observed: e4bad0a095cdfa8112a649f3d8a0794cf0078d218611bb965020b100ba368969
Size:     10,635 bytes
Status:   PASS (EXACT MATCH)
```

**Zero changes** were made to frozen manifests, protocol specifications, benchmark result summaries, or production codebase.

---

## 7. Prioritized List of Remaining Issues

- **High-Priority Scientific Issues:** None.
- **Medium-Priority Methodological Issues:** None.
- **Low-Priority Editorial Issues:** None.

All numerical figures, statistical intervals, curation bias disclosures, provenance qualifiers, comparator definitions, and literature citations are fully reconciled across all drafted manuscript sections.

---

## 8. Final Audit Verdict

```
═══════════════════════════════════════════════════════════════════════════════════
                    PHASE 5.3.2 FINAL MANUSCRIPT AUDIT VERDICT                    
═══════════════════════════════════════════════════════════════════════════════════

  FINAL VERDICT:                 PASS
  NUMERICAL ACCURACY:            100% BIT-FOR-BIT REPOSITORILY GROUNDED
  SELECTION BIAS DISCLOSURE:     EXHAUSTIVE & PROMINENT ACROSS ALL SECTIONS
  PROVENANCE ACCURACY:           100% CLINVAR DERIVED, ZERO CORROBORATION DISCLOSED
  UNREPRESENTED CLASSES:         EXPLICITLY DISCLOSED (C05, C07, C08, C10: n = 0)
  AI & COMPARATIVE CLAIMS:       FULLY QUALIFIED; ZERO INFERRED SUPERIORITY
  PROHIBITED TERMINOLOGY:        ZERO PROHIBITED CLAIMS; GROUND TRUTH DISCLAIMED
  CRYPTOGRAPHIC BASELINES:       100% BIT-FOR-BIT MATCH ACROSS ALL LOCKED MANIFESTS
  WORD COUNT COMPLIANCE:         ALL SECTIONS WITHIN PRESCRIBED TARGET RANGES

═══════════════════════════════════════════════════════════════════════════════════
```
